What this type of data looks like
Chemical pharmaceutical investment research data comes from public clinical trial databases, official patent office documents from multiple countries, pharmaceutical company R&D pipeline announcements, clinical trial registration platforms, and industry association reports. Update rhythms vary across sources: patent information updates in real time upon publication, clinical trial registration data updates monthly, and pharmaceutical company R&D pipeline announcements are released quarterly.
Individual documents include fields such as drug name, chemical structure SMILES string, target gene information, clinical trial phase, indications, adverse reaction data, patent number, issuing organization, and publication date. Units include Daltons (Da), number of cases, years of patent validity, and others. Some documents are full-length clinical trial reports in long text format.
What constraints do these characteristics impose on database and operations work?
Multi-source heterogeneous data sources require databases to support a hybrid architecture of structured table storage, semi-structured document storage, and unstructured text indexing. They also need to adapt to synchronization logic for different data formats.
Differentiated update rhythms require configuring incremental update scheduling tasks to avoid excessive resource usage from full synchronization.
Professional fields such as SMILES strings and target gene names have high precision requirements for data validation. Strict field format validation rules must be set.
Long text documents occupy more storage and indexing resources. A chunked storage and indexing strategy must be configured.
Additionally, investment research scenarios have high timeliness requirements for data. A real-time monitoring mechanism must be established to ensure data update delays meet business needs.
How to set the configurations
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Chemical pharmaceutical investment research documents are mostly long-text clinical trial reports or patent files. Standard timeout periods cannot complete full parsing |
vector_store_batch_size | 50–100 entries | Chemical pharmaceutical data has high vector dimensions, such as molecular fingerprint vectors. Excessively large batch inserts will trigger database write timeouts |
db_connection_pool_size | 10–15 | Concurrent connection requirements are high in multi-source data synchronization scenarios. This range avoids connection exhaustion |
UPLOAD_FILE_MAX_SIZE | 2000 MB | PDF or Excel files containing complete clinical trial data have large file sizes. Upload limits need to be relaxed |
mongo_max_query_time_ms | 30000 milliseconds | Complex association queries for targets and indications require longer execution times. This avoids mid-query timeout interruptions |
recall_top_k | 15–20 entries | Chemical pharmaceutical investment research requires multi-dimensional associated data. A larger number of recall results can cover more professional information |
The parameter values provided on this page are general recommendations used as a starting point for configuration. Actual values are affected by material format, data volume, and business rules. Specific issues require case-by-case analysis, and it is recommended to test on your own samples before finalizing settings.
Three common mistakes to avoid
- A 400 status code (no body) is returned when calling MySQL tools. The cause is failure to escape special format fields in chemical pharmaceutical data, such as SMILES strings and chemical formulas, leading to SQL statement syntax errors.
- A connection timeout error is displayed when connecting to MongoDB in a local development environment. The cause is failure to create composite indexes for high-frequency query fields in chemical pharmaceutical investment research data, such as target gene names and drug generic names, leading to full table scans during queries and excessive connection resource usage.
- Token consumption from model queries to MongoDB does not match actual API consumption. The cause is that vector recall returns excessively long fragments of clinical trial reports, and the
chunk_overlapparameter is not configured to control context truncation, leading to the model receiving context that exceeds the preset token range and incurring additional token consumption.
How to confirm proper configuration
- Upload a PDF document containing a complete chemical structure. Check that the parsed text retains core fields such as SMILES strings and target information, with no truncation or garbled characters.
- Run a multi-source data synchronization task. Check the database connection pool monitoring metrics, and confirm that the number of connections does not reach the configured
db_connection_pool_sizeupper limit. - Initiate a vector recall query for target genes. Verify the completeness of returned fields and the matching degree with query conditions.
- Call a MySQL tool to execute a query statement containing a chemical formula. Confirm that no syntax errors or connection exceptions are returned.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-14.